178 related articles for article (PubMed ID: 31104743)
21. Sensitivity Analysis in Sequential Decision Models.
Chen Q; Ayer T; Chhatwal J
Med Decis Making; 2017 Feb; 37(2):243-252. PubMed ID: 27681992
[TBL] [Abstract][Full Text] [Related]
22. Estimating Value-Based Price and Quantifying Uncertainty around It in Health Technology Assessment: Frequentist and Bayesian Approaches.
Hagiwara Y; Shiroiwa T
Med Decis Making; 2022 Jul; 42(5):672-683. PubMed ID: 35172648
[TBL] [Abstract][Full Text] [Related]
23. Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses.
Müller D; Pullenayegum E; Gandjour A
Eur J Health Econ; 2015 Mar; 16(2):219-23. PubMed ID: 24840608
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness and cost-utility of long-term management strategies for heartburn.
Goeree R; O'Brien BJ; Blackhouse G; Marshall J; Briggs A; Lad R
Value Health; 2002; 5(4):312-28. PubMed ID: 12102694
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness acceptability curves and a reluctance to lose.
Severens JL; Brunenberg DE; Fenwick EA; O'Brien B; Joore MA
Pharmacoeconomics; 2005; 23(12):1207-14. PubMed ID: 16336015
[TBL] [Abstract][Full Text] [Related]
26. Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the Future.
Mauskopf J
Value Health; 2019 May; 22(5):570-574. PubMed ID: 31104736
[TBL] [Abstract][Full Text] [Related]
27. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia.
Rojnik K; Naversnik K; Mateović-Rojnik T; Primiczakelj M
Value Health; 2008; 11(2):139-48. PubMed ID: 18380626
[TBL] [Abstract][Full Text] [Related]
28. Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care.
Gc VS; Suhrcke M; Hardeman W; Sutton S; Wilson ECF;
Value Health; 2018 Jan; 21(1):18-26. PubMed ID: 29304936
[TBL] [Abstract][Full Text] [Related]
29. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force.
Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E
Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of adalimumab, etanercept, and tocilizumab as first-line treatments for moderate-to-severe rheumatoid arthritis.
Soini EJ; Hallinen TA; Puolakka K; Vihervaara V; Kauppi MJ
J Med Econ; 2012; 15(2):340-51. PubMed ID: 22168785
[TBL] [Abstract][Full Text] [Related]
31. The adoption of cost-effectiveness acceptability curves in cost-utility analyses.
Meckley LM; Greenberg D; Cohen JT; Neumann PJ
Med Decis Making; 2010; 30(3):314-9. PubMed ID: 19773582
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
33. Assessing the Expected Value of Research Studies in Reducing Uncertainty and Improving Implementation Dynamics.
Grimm SE; Dixon S; Stevens JW
Med Decis Making; 2017 Jul; 37(5):523-533. PubMed ID: 28061042
[TBL] [Abstract][Full Text] [Related]
34. Health Technology Assessment With Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach.
Lakdawalla DN; Phelps CE
Value Health; 2021 Feb; 24(2):244-249. PubMed ID: 33518031
[TBL] [Abstract][Full Text] [Related]
35. Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.
Li L; Uyei J; Nucifora KA; Kessler J; Stevens ER; Bryant K; Braithwaite RS
BMC Health Serv Res; 2018 Jul; 18(1):590. PubMed ID: 30064428
[TBL] [Abstract][Full Text] [Related]
36. The use of probabilistic decision models in technology assessment : the case of total hip replacement.
Briggs A; Sculpher M; Dawson J; Fitzpatrick R; Murray D; Malchau H
Appl Health Econ Health Policy; 2004; 3(2):79-89. PubMed ID: 15702945
[TBL] [Abstract][Full Text] [Related]
37. Some Health States Are Better Than Others: Using Health State Rank Order to Improve Probabilistic Analyses.
Goldhaber-Fiebert JD; Jalal HJ
Med Decis Making; 2016 Nov; 36(8):927-40. PubMed ID: 26377369
[TBL] [Abstract][Full Text] [Related]
38. Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective.
Clarke CS; Hunter RM; Shemilt I; Serra-Sastre V
PLoS One; 2017; 12(3):e0172731. PubMed ID: 28248984
[TBL] [Abstract][Full Text] [Related]
39. Need for speed: an efficient algorithm for calculation of single-parameter expected value of partial perfect information.
Sadatsafavi M; Bansback N; Zafari Z; Najafzadeh M; Marra C
Value Health; 2013; 16(2):438-48. PubMed ID: 23538197
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.
Tuffaha HW; Roberts S; Chaboyer W; Gordon LG; Scuffham PA
Appl Health Econ Health Policy; 2015 Apr; 13(2):167-79. PubMed ID: 25650349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
